Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro1

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,736

The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death

Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,909

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789

Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6

Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B. F., Broxmeyer, H. E., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,440

SRα Promoter: an Efficient and Versatile Mammalian cDNA Expression System Composed of the Simian Virus 40 Early Promoter and the R-U5 Segment of Human T-Cell Leukemia Virus Type 1 Long Terminal Repeat

Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M., & Arai, N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.466-472.1988 · Cited by 1,330

A novel domain within the 55 kd TNF receptor signals cell death

Tartaglia, L. A., Ayres, T. M., Wong, G. H., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,290

Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule

Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,108

Modulation of Osteoclast Differentiation

Suda, T., Takahashi, N., & Martin, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004

OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION

Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-123-5-2600 · Cited by 934

Signaling pathways affected by mutations causing osteogenesis imperfecta

Etich, J., Rehberg, M., Eckes, B., Sengle, G., Semler, O., & Zaucke, F. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109789 · Cited by 50

Ascorbic acid promotes osteoclastogenesis from embryonic stem cells

Tsuneto, M., Yamazaki, H., Yoshino, M., Yamada, T., & Hayashi, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.016 · Cited by 44

Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation

Ishida, M., & Amano, S. (2004) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-004-0503-5 · Cited by 44

RANKL inhibition in the treatment of bone metastases

Lipton, A., & Jun, S. (2008) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e32830baac2 · Cited by 44

Circulating amounts of osteoprotegerin and RANK ligand: Genetic influence and relationship with BMD assessed in female twins

Abrahamsen, B., Hjelmborg, J., Kostenuik, P. J., Stilgren, L. S., Kyvik, K. O., Adamu, S., Brixen, K., & Langdahl, B. L. (2005) · Bone · doi:10.1016/j.bone.2004.12.015 · Cited by 45

Osteoprotegerin production by human intestinal epithelial cells: a potential regulator of mucosal immune responses

Vidal, K., Serrant, P., Schlosser, B., BROEK, P. V. D., Lorget, F., & Donnet‐Hughes, A. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00428.2003 · Cited by 44

Mechanisms involved in bone resorption

Udagawa, N. (2002) · Biogerontology · doi:10.1023/a:1015215615674 · Cited by 46

The potential therapeutic effects of creatine supplementation on body composition and muscle function in cancer

Fairman, C. M., Kendall, K. L., Hart, N. H., Taaffe, D. R., Galvão, D. A., & Newton, R. U. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.11.003 · Cited by 43

Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption

Wise, G. E., Yao, S., Zhang, Q., & Ren, Y. (2002) · Archives of Oral Biology · doi:10.1016/s0003-9969(01)00109-1 · Cited by 44

Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.

Han, X., Xu, Y.-J., Wang, J.-B., Pei, X.-R., Yang, R.-Y., Li, N., & Li, Y. (2009) · Bone · doi:10.1016/j.bone.2008.12.005 · Cited by 41

Osteoprotegerin and Osteoprotegerin-Ligand Balance: a New Paradigm in Bone Metabolism Providing New Therapeutic Targets

Lories, R. J. U., & Luyten, F. P. (2001) · Clinical Rheumatology · doi:10.1007/s100670170095 · Cited by 43

Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis

Ozaki, Y., Koide, M., Furuya, Y., Ninomiya, T., Yasuda, H., Nakamura, M., Kobayashi, Y., Takahashi, N., Yoshinari, N., & Udagawa, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184904 · Cited by 45

Effects of Creatine Supplementation on Properties of Muscle, Bone, and Brain Function in Older Adults: A Narrative Review

Forbes, S. C., Candow, D. G., Ferreira, L. H. B., & de Souza, T. P. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.1877232 · Cited by 65

Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin

Yasuhara, R., Miyamoto, Y., Takami, M., Imamura, T., Potempa, J., Yoshimura, K., & Kamijo, R. (2008) · Biochemical Journal · doi:10.1042/bj20081469 · Cited by 42

Current concepts in the biology of orthodontic tooth movement

Dolce, C., Malone, J. S., & Wheeler, T. T. (2002) · Seminars in Orthodontics · doi:10.1053/sodo.2002.28165 · Cited by 42

Ranking the role of RANK ligand in apoptosis

Bharti, A. C., & Aggarwal, B. B. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000045780.10463.c6 · Cited by 42

Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?

Avberšek-Lužnik, I., Balon, B. P., Rus, I., & Marc, J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh672 · Cited by 42

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma

Rédiní, F., & Heymann, D. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00279 · Cited by 42

Role of Osteoprotegerin and Its Ligands and Competing Receptors in Atherosclerotic Calcification

Tintut, Y., & Demer, L. L. (2006) · Journal of Investigative Medicine · doi:10.2310/6650.2006.06019 · Cited by 42

Renal osteodystrophy and secondary hyperparathyroidism

Fukagawa, M., Kazama, J. J., & Kurokawa, K. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_10.2 · Cited by 42

Hormonal Regulation of Osteoclast Function

Martin, T. J., & Udagawa, N. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00005-8 · Cited by 42

Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis

Mizuno, A., Murakami, A., Nakagawa, N., Yasuda, H., Tsuda, E., Morinaga, T., & Higashio, K. (1998) · Gene · doi:10.1016/s0378-1119(98)00295-9 · Cited by 42

Mechanisms of interferon-β effects on bone homeostasis

Abraham, A. K., Ramanathan, M. K., Weinstock‐Guttman, B., & Mager, D. E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.007 · Cited by 41

Zebrafish scales respond differently to in vitro dynamic and static acceleration: Analysis of interaction between osteoblasts and osteoclasts

Kitamura, K., Takahira, K., Inari, M., Satoh, Y., Hayakawa, K., Tabuchi, Y., Ogai, K., Nishiuchi, T., Kondo, T., Mikuni‐Takagaki, Y., et al. (2013) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2013.04.023 · Cited by 41

Anti-osteoporotic activity of harpagide by regulation of bone formation in osteoblast cell culture and ovariectomy-induced bone loss mouse models

Chung, H., Kim, W. K., Park, H. J., Cho, L., Kim, M.-R., Kim, M.-J., Shin, J., Lee, J. H., Ha, I., & Lee, S. K. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.025 · Cited by 41

Genes Critical for Developing Periodontitis: Lessons from Mouse Models

de Vries, T. J., Andreotta, S., Loos, B. G., & Nicu, E. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01395 · Cited by 41

Molecular Mechanisms Leading from Periodontal Disease to Cancer

Sobocki, B. K., Basset, C. A., Bruhn-Olszewska, B., Olszewski, P., Szot, O., Kaźmierczak-Siedlecka, K., Guziak, M., Nibali, L., & Leone, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020970 · Cited by 42

Inhibition of osteoclast formation by 3-methylcholanthrene, a ligand for arylhydrocarbon receptor: suppression of osteoclast differentiation factor in osteogenic cells

Naruse, M., Otsuka, E., Naruse, M., Ishihara, Y., Miyagawa‐Tomita, S., & Hagiwara, H. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.038 · Cited by 41

Isopropanolic Extract of Black Cohosh Stimulates Osteoprotegerin Production by Human Osteoblasts

Viereck, V., Gründker, C., Friess, S. C., Frosch, K., Raddatz, D., Schoppet, M., Nißlein, T., Emons, G., & Hofbauer, L. C. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050716 · Cited by 41

Bone remodeling: A review of the bone microenvironment perspective for fragility fracture (osteoporosis) of the hip

Fazzalari, N. L. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.08.003 · Cited by 41

Interleukin-4 Cellular Gene Therapy and Osteoprotegerin Decrease Inflammation-Associated Bone Resorption in Collagen-Induced Arthritis

Saidenberg-Kermanac’h, N., Bessis, N., Lemeiter, D., de Vernejoul, M. C., Boissier, M., & Cohen-Solal, M. E. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000029116.12371.bf · Cited by 41

Osteoprotegerin Inhibits Calcification of Vascular Smooth Muscle Cell via Down Regulation of the Notch1-RBP-Jκ/Msx2 Signaling Pathway

Zhou, S., Fang, X., Xin, H., Li, W., Qiu, H., & Guan, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068987 · Cited by 40

Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis

Lane, D. A., Matte, I., Laplante, C., Garde‐Granger, P., Rancourt, C., & Piché, A. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-82 · Cited by 40

Tetracyclines Convert the Osteoclastic-Differentiation Pathway of Progenitor Cells To Produce Dendritic Cell-like Cells

Kinugawa, S., Koide, M., Kobayashi, Y., Mizoguchi, T., Ninomiya, T., Muto, A., Kawahara, I., Nakamura, M., Yasuda, H., Takahashi, N., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101174 · Cited by 42

Retardation in Bone Resorption after Bone Marrow Ablation in Klotho Mutant Mice1

Yamashita, T., Yoshitake, H., Tsuji, K., Kawaguchi, N., Nabeshima, Y., & Noda, M. (2000) · Endocrinology · doi:10.1210/endo.141.1.7252 · Cited by 40

Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506

Fukunaga, J., Yamaai, T., Yamachika, E., Ishiwari, Y., Tsujigiwa, H., Sawaki, K., Lee, Y. J., Ueno, T., Kirino, S., Mizukawa, N., et al. (2003) · Bone · doi:10.1016/j.bone.2003.05.003 · Cited by 40

The Role of TNF‐α and TNF Superfamily Members in the Pathogenesis of Calcific Aortic Valvular Disease

Galeone, A., Paparella, D., Colucci, S. C., Grano, M., & Brunetti, G. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/875363 · Cited by 43

Generation of Human Osteoclasts from Peripheral Blood

Henriksen, K., Karsdal, M. A., Taylor, A., Tosh, D., & Coxon, F. P. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-415-5_11 · Cited by 40

The nicotinic acetylcholine receptor α7 subunit is an essential negative regulator of bone mass

Mito, K., Sato, Y., Kobayashi, T., Miyamoto, K., Nitta, E., Iwama, A., Matsumoto, M., Nakamura, M., Sato, K., & Miyamoto, T. K. (2017) · Scientific Reports · doi:10.1038/srep45597 · Cited by 39

Osteoblast Maturation Suppressed Osteoclastogenesis in Coculture with Bone Marrow Cells

Deyama, Y., Takeyama, S., Koshikawa, M., Shirai, Y., Yoshimura, Y., Nishikata, M., Suzuki, K., & Matsumoto, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3127 · Cited by 39

Immunological Study on Circulating Murine Osteoprotegerin/Osteoclastogenesis Inhibitory Factor (OPG/OCIF): Possible Role of OPG/OCIF in the Prevention of Osteoporosis in Pregnancy

Yano, K., Shibata, O., Mizuno, A., Kobayashi, F., Higashio, K., Morinaga, T., & Tsuda, E. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5745 · Cited by 41

Increased mRNA expression and protein secretion of interleukin‐6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone

Chenoufi, H.-L., Diamant, M., Rieneck, K., Lund, B., Stein, G. S., & Lian, J. B. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1104 · Cited by 39

Regulation of osteoprotegerin pro- or anti-tumoral activity by bone tumor microenvironment

Lamoureux, F., Moriceau, G., Picarda, G. G. A., Rousseau, J., Trichet, V., & Rédiní, F. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.08.004 · Cited by 43

Osteoclast biology in the single-cell era

Tsukasaki, M., & Takayanagi, H. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00213-x · Cited by 53

RANK(L) as a Key Target for Controlling Bone Loss

Leibbrandt, A., & Penninger, J. M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_9 · Cited by 37

Cell Fusion in Health and Disease

Dittmar, T., & Zänker, K. S. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0763-4 · Cited by 41

Anti-Osteoporotic Activity of Harpagoside by Upregulation of the BMP2 and Wnt Signaling Pathways in Osteoblasts and Suppression of Differentiation in Osteoclasts

Chung, H., Kim, W. K., Oh, J., Kim, M.-R., Shin, J., Lee, J., Ha, I., & Lee, S. K. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00964 · Cited by 38

Association Between Indoxyl Sulfate and Skeletal Resistance in Hemodialysis Patients

Goto, S., Fujii, H., Hamada, Y., Yoshiya, K., & Fukagawa, M. (2010) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2010.00813.x · Cited by 38

Bone Structure, Development and Bone Biology

Khurana, J. S., & Safadi, F. F. (2009) · Springer eBooks · doi:10.1007/978-0-387-89845-2_1 · Cited by 41

Estrogen Regulates Expression of Osteoprotegerin and RANKL in Human Periodontal Ligament Cells Through Estrogen Receptor Beta

Li, L., Yu, J., Wang, Y., & Ding, Y. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.070437 · Cited by 38

Bone metastasis in breast cancer: The story of RANK-Ligand

Azim, H. A., Kamal, N. S., & Azim, H. A. (2012) · Journal of the Egyptian National Cancer Institute · doi:10.1016/j.jnci.2012.06.002 · Cited by 38

IL-24 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas

Ross, B. X., Gao, N., Cui, X., Standiford, T. J., Xu, J., & Yu, F. X. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602087 · Cited by 40

Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases

Fukagawa, M., Kazama, J. J., & Shigematsu, T. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27426 · Cited by 38

Cellular and molecular mechanism of low-turnover osteopenia in the klotho -deficient mouse

Kawaguchi, H., MANABE, N., Chikuda, H., Nakamura, K., & Kuro‐o, M. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050037 · Cited by 38

OPG/RANK/RANKL signaling system and its significance in nephrology.

Klejna, K., Naumnik, B., Gąsowska, K., & Myśliwiec, M. (2009) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-009-0035-x · Cited by 37

Cigarette smoke-induced RANKL expression enhances MMP-9 production by alveolar macrophages

Zhou, L., Le, Y., Tian, J., Yang, X., Jin, R., Gai, X., & Sun, Y. (2018) · International Journal of COPD · doi:10.2147/copd.s190023 · Cited by 38

The Central Regulation of Bone Remodeling

Karsenty, G. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00322-2 · Cited by 37

Diphenylhydantoin Inhibits Osteoclast Differentiation and Function Through Suppression of NFATc1 Signaling

Koide, M., Kinugawa, S., Ninomiya, T., Mizoguchi, T., Yamashita, T., Maeda, K., Yasuda, H., Kobayashi, Y., Nakamura, H., Takahashi, N., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090302 · Cited by 37

The effects of C161→T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-γ gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women

Rhee, E., Oh, K.-W., Lee, W., Kim, S.-Y., Oh, E.-S., Baek, K., Kang, M.-I., & Kim, S.-W. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.09.033 · Cited by 34

Mediators of Inflammation-Induced Bone Damage in Arthritis and Their Control by Herbal Products

Nanjundaiah, S. M., Astry, B., & Moudgil, K. D. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/518094 · Cited by 40

Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.

Ainola, M., Mandelin, J. M., Liljeström, M., Konttinen, Y. T., & Salo, J. (2008) · PubMed · Cited by 35

Bone Status in Patients with Epilepsy: Relationship to Markers of Bone Remodeling

Hamed, S. A., Moussa, E. M. M., Youssef, A. H., ElHameed, M. A. A., & NasrEldin, E. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00142 · Cited by 36

Minireview: Nuclear Receptor Regulation of Osteoclast and Bone Remodeling

Jin, Z., Li, X., & Wan, Y. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1316 · Cited by 38

Genetic background influences metabolic response to dietary phosphorus restriction

Hittmeier, L. J., Grapes, L., Lensing, R. L., Rothschild, M. F., & Stahl, C. H. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.08.008 · Cited by 36

Effects of soluble silicon compound and deep-sea water on biochemical and mechanical properties of bone and the related gene expression in mice

Maehira, F., Iinuma, Y., Eguchi, Y., Miyagi, I., & Teruya, S. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0845-x · Cited by 36

Characterization of epithelial cells derived from periodontal ligament by gene expression patterns of bone-related and enamel proteins

MIZUNO, N., SHIBA, H., Mouri, Y., Wang, X., Kudoh, S., Kawaguchi, H., & KURIHARA, H. (2005) · Cell Biology International · doi:10.1016/j.cellbi.2004.11.012 · Cited by 36

Development of Small-Molecules Targeting Receptor Activator of Nuclear Factor-κB Ligand (RANKL)—Receptor Activator of Nuclear Factor-κB (RANK) Protein–Protein Interaction by Structure-Based Virtual Screening and Hit Optimization

Jiang, M., Peng, L., Yang, K., Wang, T., Yan, X., Jiang, T., Xu, J., Jin, Q., Zhou, H., Qian, N., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b02027 · Cited by 35

Normal human primary CD4+ T lymphocytes synthesize and release functional osteoprotegerin in vitro

Chakravarti, A., Marceau, A.-A., Flamand, L., & Poubelle, P. E. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700701 · Cited by 35

Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas

Ishikuro, M., Sakamoto, K., Kayamori, K., Akashi, T., Kanda, H., Izumo, T., & Yamaguchi, A. (2008) · Bone · doi:10.1016/j.bone.2008.05.014 · Cited by 35

Effects of a sulfated exopolysaccharide produced by Altermonas infernus on bone biology

Velasco, C. R., Baud’huin, M., Sinquin, C., Maillasson, M., Heymann, D., Colliec‐Jouault, S., & Padrines, M. (2011) · Glycobiology · doi:10.1093/glycob/cwr002 · Cited by 35

Nitric Oxide Donor Increases Osteoprotegerin Production and Osteoclastogenesis Inhibitory Activity in Bone Marrow Stromal Cells from Ovariectomized Rats

Wang, F.-S., Wang, C.-J., Chen, Y.-J., Huang, Y.-T., Huang, H.-C., Chang, P.-R., Sun, Y.-C., & Yang, K. D. (2004) · Endocrinology · doi:10.1210/en.2003-1074 · Cited by 35

Sequential requirements for SCL/tal-1, GATA-2, macrophage colony-stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development

Yamane, T., Kunisada, T., Yamazaki, H., Nakano, T., Orkin, S. H., & Hayashi, S. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00175-2 · Cited by 35

Bone markers in the management of patients with skeletal metastases

Demers, L. M. (2003) · Cancer · doi:10.1002/cncr.11127 · Cited by 35

Differential Regulation of the Expression of CD95 Ligand, Receptor Activator of Nuclear Factor-κB Ligand (RANKL), TNF-Related Apoptosis-Inducing Ligand (TRAIL), and TNF-α During T Cell Activation

Wang, R., Zhang, L., Zhang, X., Moreno, J. L., Luo, X., Tondravi, M. M., & Shi, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1983 · Cited by 34

Vitamin D and Osteoclastogenesis

Yasuda, H., Higashio, K., & Suda, T. (2005) · Elsevier eBooks · doi:10.1016/b978-012252687-9/50041-3 · Cited by 35

Expression of tumour necrosis factor-alpha in the rat dental follicle.

Wise, G. E., & Yao, S. (2003) · Archives of Oral Biology · doi:10.1016/s0003-9969(02)00153-x · Cited by 38

Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences

Heymann, D. (2012) · Journal of bone oncology · doi:10.1016/j.jbo.2012.03.001 · Cited by 36

Targeting bone metastatic cancer: Role of the mTOR pathway

Bertoldo, F., Silvestris, F., Ibrahim, T., Cognetti, F., Generali, D., Ripamonti, C. I., Amadori, D., Colleoni, M. A., Conte, P., Mastro, L. D., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.009 · Cited by 34

Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts

Jacobson, A., Johansson, S., Branting, M., & Melhus, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.092 · Cited by 52

Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples

Seck, T. L., Diel, I., Bismar, H., Ziegler, R., & Pfeilschifter, J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450199 · Cited by 34

Role of osteoclasts in regulating hematopoietic stem and progenitor cells

Miyamoto, T. K. (2013) · World Journal of Orthopedics · doi:10.5312/wjo.v4.i4.198 · Cited by 37

Transforming growth factor‐β stimulates Interleukin‐11 production by human periodontal ligament and gingival fibroblasts

Yashiro, R., Nagasawa, T., Kiji, M., Hormdee, D., Kobayashi, H., Koshy, G., Nitta, H., & Ishikawa, I. (2006) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2006.00898.x · Cited by 33

Tuning of Innate Immunity and Polarized Responses by Decoy Receptors

Mantovani, A., Bonecchi, R., Martínez, F. O., Galliera, E., Perrier, P., Allavena, P., & Locati, M. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000073711 · Cited by 33

Organogenesis of the exocrine gland

Wang, J., & Laurie, G. W. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.05.025 · Cited by 34

Porphyromonas gingivalis regulates the RANKL-OPG system in bone marrow stromal cells

Reddi, D., Bostancı, N., Hashim, A., Aduse‐Opoku, J., Curtis, M. A., Hughes, F. J., & Belibasakis, G. N. (2008) · Microbes and Infection · doi:10.1016/j.micinf.2008.08.007 · Cited by 33

Fluid flow induces Rankl expression in primary murine calvarial osteoblasts

Mehrotra, M., Saegusa, M., Wadhwa, S., Voznesensky, O. S., Peterson, D., & Pilbeam, C. C. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20864 · Cited by 33

Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond

Deligiorgi, M. V., Panayiotidis, M. I., Grınıatsos, J., & Trafalis, D. T. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09997-8 · Cited by 32

Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males

Findlay, D. M., Chehade, M. J., Tsangari, H., Neale, S. D., Hay, S. J., Hopwood, B., Pannach, S., O’Loughlin, P. D., & Fazzalari, N. L. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2348 · Cited by 33

ELISA Methodology for Detection of Modified Osteoprotegerin in Clinical Studies

Chen, D., Sarikaya, N., Gunn, H., Martin, S. W., & Young, J. D. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.747 · Cited by 32

Genetic and molecular aspects of osteosarcoma.

Hansen, M. (2002) · PubMed · Cited by 32

A perspective on the beneficial effects of moderate exposure to sunlight: bone health, cancer prevention, mental health and well being

Holick, M. F. (2001) · Comprehensive series in photosciences · doi:10.1016/s1568-461x(01)80037-5 · Cited by 32

Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation

Mandelin, J., Liljeström, M., Li, T., Ainola, M., Hukkanen, M., Salo, J., Santavirta, S. S., & Konttinen, Y. T. (2005) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.30244 · Cited by 32

Effects of Enamel Matrix Derivative on Bone‐Related mRNA Expression in Human Periodontal Ligament Cells In Vitro

Takayanagi, K., Osawa, G., Nakaya, H., Cochran, D. L., Kamoi, K., & Oates, T. W. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.050244 · Cited by 32

Genomic Expression Discovery Predicts Pathways and Opposing Functions behind Phenotypes

Fathallah‐Shaykh, H. M., He, B., Zhao, L.-J., Engelhard, H. H., Cerullo, L. J., Lichtor, T., Byrne, R. W., Munoz, L. F., Roenn, K. A. V., Rosseau, G. L., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302800200 · Cited by 32

Identification of signal transduction pathways and promoter sequences that mediate parathyroid hormone 1–38 inhibition of osteoprotegerin gene expression

Halladay, D., Miles, R. R., Thirunavukkarasu, K., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1273 · Cited by 32

Is aplastic osteodystrophy a disease of malnutrition?

Fukagawa, M., Akizawa, T., & Kurokawa, K. (2000) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200007000-00007 · Cited by 32

Osteoprotegerin inhibits in vitro mouse osteoclast formation induced by joint fluid from failed total hip arthroplasty

Kim, K. J., Kotake, S., Udagawa, N., Ida, H., Ishii, M., Takei, I., Kubo, T., & Takagi, M. (2001) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1033 · Cited by 32

Comparison of the effects of 17β-E2 and progesterone on the expression of osteoprotegerin in normal human osteoblast-like cells

Liao, E. Y., Luo, X., & Su, X. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03345513 · Cited by 32

Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor

Yano, K., Nakagawa, N., Yasuda, H., Tsuda, E., & Higashio, K. (2001) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740170006 · Cited by 32

The synergistic effect of peptidoglycan and lipopolysaccaride on osteoclast formation

Jiang, J. Q., Zuo, J., Hurst, I. R., & Holliday, L. S. (2003) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2003.08.006 · Cited by 31

A novel molecular mechanism modulating osteoclast differentiation and function

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Goto, M., Mochizuki, S.-I., Tsuda, E., Morinaga, T., Udagawa, N., et al. (1999) · Bone · doi:10.1016/s8756-3282(99)00121-0 · Cited by 264

Osteoclast Differentiation Factor is a Ligand for Osteoprotegerin / Osteoclastogenesis-Inhibitory Factor

Shima, N., Yasuda, H., Nakagawa, N., Yamaguchi, K., Tsuda, E., Morinaga, T., Suda, T., & Higashio, K. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46869-7_43 · Cited by 1

Recent Advance in Osteoclastogenesis Inhibitory Factor.

Zhi, H. (2000) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS

16. Lack of antagonist activity of melanocyte-stimulating hormone (MSH) on the actions of IL-1 on human bone-derived osteoblast-like cells

Evans, D., Thavarajah, M., & Kanis, J. A. (1991) · Bone · doi:10.1016/8756-3282(91)90112-v

Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells

Takai, H., Kanematsu, M., Yano, K., Tsuda, E., Higashio, K., Ikeda, K., Watanabe, K., & Yamada, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27091 · Cited by 299